Pfizer Inc.
PFENYSE
$30.28
Last price · USD
- Market cap
- $172.2B
- P/E
- 22.3x
- EV / EBITDA
- 14.2x
- P/S
- 2.8x
- FCF yield
- 5.3%
- Div. yield
- 5.68%
Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.
Pfizer Inc. key metrics & ratios
Annual · USD millions except per-share data · 36 lines
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | CAGR | |
|---|---|---|---|---|---|---|---|
| Growth (year over year) | |||||||
| Revenue growth | -1.6% | 6.8% | -40.6% | 23.4% | — | — | |
| Operating income growth | -6.3% | 211.5% | -85.9% | 80.6% | — | — | |
| Net income growth | -3.1% | 276.0% | -93.2% | 41.6% | — | — | |
| EPS (diluted) growth | -3.5% | 279.8% | -93.2% | 41.0% | — | — | |
| Free cash flow growth | -7.7% | 105.2% | -81.6% | -12.8% | — | — | |
| Margins | |||||||
| Gross margin | 70.3% | 65.8% | 50.9% | 61.9% | 57.7% | — | |
| Operating margin | 24.7% | 25.9% | 8.9% | 37.4% | 25.6% | — | |
| EBITDA margin | 26.8% | 28.5% | 16.0% | 40.9% | 37.9% | — | |
| Net margin | 12.4% | 12.6% | 3.6% | 31.3% | 27.2% | — | |
| FCF margin | 14.5% | 15.5% | 8.0% | 25.9% | 36.7% | — | |
| Returns on capital | |||||||
| Return on equity | 9.0% | 9.1% | 2.4% | 32.8% | 28.7% | — | |
| Return on assets | 3.7% | 3.8% | 0.9% | 15.9% | 12.2% | — | |
| Return on invested capital | 10.1% | 10.7% | 3.4% | 26.1% | 17.1% | — | |
| Leverage & liquidity | |||||||
| Debt / equity | 0.78x | 0.76x | 0.80x | 0.36x | 0.48x | — | |
| Net debt / EBITDA | 3.95x | 3.64x | 7.11x | 0.84x | 1.14x | — | |
| Current ratio | 1.16x | 1.17x | 0.91x | 1.22x | 1.40x | — | |
| Interest coverage | 5.78x | 5.33x | 2.40x | 30.33x | 16.11x | — | |
| Profitability & operating | |||||||
| EBIT | 10,191 | 11,114 | 3,267 | 35,967 | 25,602 | -20.6% | |
| EBITDA | 16,783 | 18,127 | 9,557 | 41,031 | 30,793 | -14.1% | |
| Operating income | 15,437 | 16,483 | 5,292 | 37,549 | 20,793 | -7.2% | |
| Income before tax | 7,520 | 8,023 | 1,058 | 34,729 | 24,311 | -25.4% | |
| Net income | 7,770 | 8,020 | 2,133 | 31,365 | 22,147 | -23.0% | |
| Earnings per share | |||||||
| EPS (basic) | $1.36 | $1.42 | $0.38 | $5.59 | $3.95 | -23.4% | |
| EPS (diluted) | $1.36 | $1.41 | $0.37 | $5.47 | $3.88 | -23.1% | |
| Share count (millions) | |||||||
| Weighted avg shares outstanding | 5,683 | 5,664 | 5,643 | 5,608 | 5,601 | +0.4% | |
| Weighted avg shares outstanding (diluted) | 5,686 | 5,700 | 5,709 | 5,733 | 5,708 | -0.1% | |
| Balance sheet highlights | |||||||
| Net debt | 66,274 | 65,950 | 67,992 | 34,443 | 35,054 | +17.3% | |
| Total debt | 67,416 | 66,993 | 70,845 | 34,859 | 36,998 | +16.2% | |
| Total investments | 14,191 | 21,661 | 25,205 | 37,385 | 50,651 | -27.2% | |
| Total stockholders' equity | 86,476 | 88,203 | 89,014 | 95,661 | 77,201 | +2.9% | |
| Total assets | 208,160 | 213,396 | 226,501 | 197,206 | 181,477 | +3.5% | |
| Cash flow highlights | |||||||
| Free cash flow | 9,076 | 9,835 | 4,793 | 26,031 | 29,869 | -25.8% | |
| Operating cash flow | 11,705 | 12,744 | 8,700 | 29,267 | 32,580 | -22.6% | |
| Capital expenditure | (2,629) | (2,909) | (3,907) | (3,236) | (2,711) | — | |
| Net cash from operating activities | 11,705 | 12,744 | 8,700 | 29,267 | 32,580 | -22.6% | |
| Additional fields | |||||||
| Accrued Expenses | 3,610 | 0 | 0 | 0 | 0 | — | |